Screener / SEC EDGAR /CIK 0000896622 /10-K filed Feb 6, 2026, compared with Feb 7, 2025 /Numbers from the XBRL of the 10-Ks
NYSE Materials · Plastics Products

Aptargroup, Inc. ATR

Compare with peers Embed
In the footnotes

What the 10-K filed Feb 6, 2026 says off the balance sheet

10-K notes
Topics with specifics 5 of 6 with a sentence that gives amounts, accruals or ratios
Sentences quoted 11 word for word, each linked to the 10-K
New this year 4 sentences with nothing like them in the 10-K filed Feb 7, 2025

Risks that are not on the face of the balance sheet. Tickdelta picks sentences with specifics and quotes them as filed. New marks a sentence with nothing like it in the 10-K filed Feb 7, 2025.

Big customers

Customers the company names as a large share of revenue or receivables (it must name any worth 10% of revenue).

No specific sentence about this in the 10-K.

Key suppliers

Parts or manufacturing that depend on one or a few suppliers.

“Our ability to adequately source materials including those from a single supplier or from a single manufacturing location, could adversely impact our ability to deliver our products.”

Read it in the 10-K

“In some cases, we have historically sourced certain materials, especially some resins and rubber components for our Pharma segment, from a single source.”

Read it in the 10-K

“the availability of raw materials and components (particularly from sole-sourced suppliers for some of our Pharma solutions) as well as the financial viability of these suppliers;”

Read it in the 10-K

Lawsuits and legal claims

Pending cases, settlements and what the company has set aside for them.

4 new

New “For the year ended December 31, 2025, “other special items” include costs incurred related to non-ordinary-course litigation, specifically: lawsuits between Aptar and ARS Pharmaceuticals, Inc. involving Aptar’s claims of trade-secret misappropriation and contractual breaches and ARS’s counterclaims under U.S. antitrust laws; and patent infringement actions filed by Nemera La Verpillière SAS in Germany and France relating to certain of Aptar’s ophthalmic products.”

Read it in the 10-K

New “On March 25, 2025, AptarGroup, Inc. and its subsidiary, Aptar France SAS, filed a lawsuit in the United States District Court for the Southern District of New York against ARS Pharmaceuticals, Inc. and ARS Pharmaceuticals Operations, Inc.”

Read it in the 10-K

New “Relatedly, on September 29, 2025, ARS filed a lawsuit in the United States District Court for the Southern District of California against Aptar.”

Read it in the 10-K

New “In May 2025, Nemera La Verpillière SAS ("Nemera") filed parallel patent infringement actions in Mannheim Regional Court, Germany and Paris Judicial Court, France against Aptar and certain subsidiaries alleging that Aptar's ophthalmic product infringes a Nemera patent, seeking an injunction and damages.”

Read it in the 10-K

“In 2022, we filed a lawsuit against the insurance company to recover a part of our claim.”

Read it in the 10-K

Guarantees and indemnities

Promises to pay someone else's debts or losses if they cannot.

“The maximum potential amount of future payments we could be required to make under these indemnification agreements is unlimited; however, we have a directors and officers liability insurance policy that covers a portion of our exposure.”

Read it in the 10-K

Debt covenants

Conditions in loan agreements that, if broken, can make debt due early.

“Based upon the above consolidated leverage ratio covenant, we would have the ability to borrow an additional $1.70 billion before the 3.50 to 1.00 maximum ratio requirement would be exceeded.”

Read it in the 10-K

Commitments off the balance sheet

Contracts the company must pay for later: purchase obligations, take-or-pay deals.

“As of December 31, 2025, we have unconditional purchase commitments of approximately $56.2 million of which the majority relate to open purchase orders for fixed assets over the next three years, for which no liabilities have been recorded.”

Read it in the 10-K
Customers it names 0 tracked companies its filings call a customer
Suppliers it names 0 tracked companies its filings call a supplier
Companies that name it 0 tracked companies whose filings call it a customer or a supplier

Companies it names

Tracked companies that its latest 10-K or its 8-Ks of the last year call a customer or a supplier.

No other tracked company is named as a customer or a supplier in the latest filings.

Companies that name it

Tracked companies whose latest 10-K or 8-Ks call it a customer or a supplier.

No other tracked company names it as a customer or a supplier in the latest filings.

Sentences are chosen by their words, not read by AI, so some can be off topic. Always check the filing. Open the 10-K

Sources

The notes to the financial statements, Legal Proceedings and the MD&A of the latest 10-K (and, for customers and suppliers, Business and Risk Factors), quoted as filed.

Also

Debt: the debt note in numbers.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/ATR/export.csv") into a cell.

Next:Reverse DCF
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.